1. Altenburg J, De Graaff CS, Stienstra Y et al (2013) Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 309:1251–1259
2. Andres J, Hellmann A, Horst M (2011) Versorgungsbericht 2010 – ambulante Pneumologie. Bundesverband der Pneumologen (BdP) in Kooperation mit dem Wissenschaftlichen Informationsnetzwerk der niedergelassenen Pneumologen (WINPNEU), Heidenheim
3. Bronchiectasis (2013). In: Gibson J, Loddenkemper R, Sibille Y, Lundbäck B (eds) The European Lung White Book: Respiratory Health and Disease in Europe. European Respiratory Society, Lausanne, S. 176–183
4. Barker A, O’donnell A, Thompson PJ et al (2013) Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB). Eur Respir J 42:877–878
5. De Soyza A, Brown JS, Loebinger MR (2013) Research priorities in bronchiectasis. Thorax 68:695–696